MYD88 and Cognitive impairment: Therefore, we hypothesise that cancer pain patients carrying the rs6853 SNP are at lower risk of developing cognitive dysfunction due to reduced MyD88 activity driving the neuroimmune signalling associated with cognitive impairment.